CRON Q4 2021 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

Q4 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$33M+91.4% YoY

Gross Profit

$2M7.5% margin

Operating Income

-$206M-630.5% margin

Net Income

-$169M-518.1% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

+59.8%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$37M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$63M

Stockholders' Equity

$1.3B

Cash & Equivalents

$887M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$17M	+91.4%
Gross Profit	$2M	-$15M	+116.5%
Operating Income	-$206M	-$58M	-252.1%
Net Income	-$169M	-$111M	-51.9%

Revenue Segments

Cannabis Flower

$19M73%

Cannabis Extracts

$7M27%

Product and Service, Other

$45,0000%

Geographic Segments

CANADA

$18M69%

ISRAEL

$5M19%

UNITED STATES

$3M12%

Other Countries

$31,0000%